Purpose
to facilitate and speed the development and licensure of a safe, effective prophylactic HIV-1 vaccine that can be globally deployed to halt the HIV-1 pandemic
Grantee
Division
Global Health
Date
OCTOBER 2011
Region served
GLOBAL
Committed amount
$3,329,465
Grant topic
HIV
Duration (months)
41
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.